FindTrial
Sign In

Association between statin use and daptomycin-related musculoskeletal adverse events: meta-analysis

Association between statin use and daptomycin-related musculoskeletal adverse events: meta-analysis - Association between statin use and daptomycin-related musculoskeletal adverse events: meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000046414
Enrollment
Unknown
Registered
2021-12-20
Start date
2019-11-30
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients treated with daptomycin

Interventions

None listed

Sponsors

Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Reports examined the effects of statin use on DAP-related MAEs

Exclusion criteria

Exclusion criteria: Reports fulfilled criteria with letters/correspondence, case reports, relevant reviews, not controlled arm, unclear outcome.

Design outcomes

Primary

MeasureTime frame
The effects of statin use on DAP-related MAEs—

Countries

Japan

Contacts

Public ContactMasayuki Chuma

Asahikawa Medical University Department of Hospital Pharmacy and Pharmacology

chuma-masayuki@asahikawa-med.ac.jp0166-69-3482

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026